QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 171 filers reported holding QIAGEN NV in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,056,000 | -2.5% | 216,129 | -4.5% | 0.01% | 0.0% |
Q3 2016 | $6,212,000 | +33.8% | 226,375 | +6.3% | 0.01% | +25.0% |
Q2 2016 | $4,644,000 | -5.6% | 212,939 | -3.3% | 0.00% | 0.0% |
Q1 2016 | $4,920,000 | -57.1% | 220,255 | -46.9% | 0.00% | -60.0% |
Q4 2015 | $11,469,000 | +74.6% | 414,786 | +62.9% | 0.01% | +66.7% |
Q3 2015 | $6,569,000 | +19.9% | 254,629 | +15.2% | 0.01% | +20.0% |
Q2 2015 | $5,481,000 | -45.2% | 221,107 | -44.4% | 0.01% | -37.5% |
Q1 2015 | $10,006,000 | +154.5% | 397,799 | +137.4% | 0.01% | +166.7% |
Q4 2014 | $3,932,000 | -14.8% | 167,584 | -17.3% | 0.00% | -25.0% |
Q3 2014 | $4,613,000 | -6.8% | 202,584 | +0.0% | 0.00% | 0.0% |
Q2 2014 | $4,951,000 | +24.1% | 202,484 | +7.0% | 0.00% | +33.3% |
Q1 2014 | $3,990,000 | -40.6% | 189,190 | -32.9% | 0.00% | -50.0% |
Q4 2013 | $6,714,000 | +7.7% | 281,992 | -3.2% | 0.01% | 0.0% |
Q3 2013 | $6,234,000 | +7.8% | 291,322 | +0.3% | 0.01% | 0.0% |
Q2 2013 | $5,782,000 | – | 290,391 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tikvah Management LLC | 369,425 | $9,032,000 | 6.36% |
Hardman Johnston Global Advisors LLC | 4,586,856 | $112,149,000 | 5.99% |
Eclectica Asset Management LLP | 90,950 | $2,223,000 | 2.21% |
Douglas C. Lane & Associates, Inc. | 1,970,371 | $48,176,000 | 1.46% |
HARDING LOEVNER LP | 6,978,369 | $170,621,000 | 1.27% |
CRAMER ROSENTHAL MCGLYNN LLC | 3,911,835 | $95,644,000 | 0.77% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $43,547,000 | 0.76% |
GLG Partners LP | 1,220,148 | $29,833,000 | 0.71% |
Sivik Global Healthcare LLC | 49,451 | $1,209,000 | 0.61% |
PRIMECAP MANAGEMENT CO/CA/ | 22,087,404 | $540,037,000 | 0.59% |